PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 22, 2004 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Baxa Names Jim Osgood as Vice President of Product Planning, Research and Development

Baxa Corporation, a leading provider of devices and systems for safe preparation, handling, packaging and administration of liquid medications, announces the appointment of Jim Osgood as Vice President of Product Planning, Research and Development. In this position, Osgood is responsible for the strategic planning, business intelligence and R&D for developing new products and technologies for the company.

Englewood, CO (PRWEB) September 22, 2004 -- Baxa Corporation, a leading provider of devices and systems for safe preparation, handling, packaging and administration of liquid medications, announces the appointment of Jim Osgood as Vice President of Product Planning, Research and Development.

In this position, Osgood is responsible for the strategic planning, business intelligence and R&D for developing new products and technologies for the company. "Jim is a strong addition to the leadership at Baxa, bringing more than 15 years' experience in new product development and cross-functional team management to his position," said Greg Baldwin, CEO and President of Baxa. "We look forward to the fresh perspective he brings to our focus on developing innovative products for the markets we serve."

Prior to joining Baxa, Osgood was Vice President, New Product Development & Innovation for The Coleman Company, a $750 million global business that markets and sells consumer outdoor recreation equipment. There, he successfully led the development and commercialization of more than 60 new product and advanced technology projects, revamped the new product development process, improving profitability and speed-to-market through high-performance teams and innovation. Osgood's experience includes business planning and market development for First Data Corporation, and business unit management and new product development positions with Teledyne Water Pik, where he overhauled strategic plans that consistently contributed double-digit annual growth.

He also worked for Unicover Corporation, where he was in charge of product management and marketing, distribution, licensing and operations for various US and international businesses.

Osgood is an active member of the Product Development and Management Association and is a certified New Product Development Professional (NPDP). He earned his Bachelor's Degree in Business Management at the University of Wyoming.

About Baxa Corporation:
As a leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com.

# # #

Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com

# # #

Other Releases by this Member
OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Maggie Holben
ABSOLUTELY PUBLIC RELATIONS
303-984-9801
Email us Here
View Our Newsroom
ATTACHED FILES

Jim Osgood, Baxa Corporation
Vice President of Product Planning, Research and Development

Baxa Corporation
Englewood, CO

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.